Given the political uncertainty in the US under the current administration, should Indian life sciences students also apply to Singapore, Germany, or the UK for their master's or PhD?

Yes, applying to multiple countries simultaneously is sensible and is what most competitive life sciences applicants globally are doing in the current environment. Visa processing times and policy uncertainty in the US have materially increased the risk of applying exclusively to US programs. Singapore is a strong alternative for life sciences research, with NTU specifically being a well-regarded destination that has attracted strong Indian students in recent years. NUS also has competitive life sciences programs and a well-funded research environment.

• Germany offers PhD positions that often include a stipend and tuition exemption at public universities, and the life sciences ecosystem, particularly in Munich, Heidelberg, and Berlin, is internationally competitive.
• The UK offers one-year PhD-track research master's programs and a Graduate Route visa that allows post-study work.
• The practical approach is to treat the US applications as the primary target while applying to two or three international alternatives in parallel, so that if US visa processing creates a timeline problem, you have confirmed alternatives ready.
• Given the investment of time and money in any postgraduate application cycle, portfolio diversification across countries is straightforward risk management.